lung tumors
The incidence of KRAS2 mutations in human compared to mouse lung tumors differed significantly, as did the incidence of Hras and p53 gene mutations in human compared to mouse liver tumors.
The incidence of KRAS2 mutations in human compared to mouse <span class="disease" id="16410370-8-60-71">lung tumors</span> differed significantly, as did the incidence of Hras and <span class="gene" id="16410370-8-129-132">p53</span> gene mutations in human compared to mouse liver tumors.